More about

Allergic Asthma

News
December 04, 2024
2 min read
Save

Dupilumab improved lung function, reduced exacerbations in children with type 2 asthma

BOSTON — Dupilumab reduced exacerbations and improved lung function in children with asthma, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

News
September 05, 2024
3 min read
Save

Q&A: How physicians can gear up for peak asthma month in September

As fall draws near, so does the season for viruses and environmental allergens, which can trigger asthma. Experts say that with children returning to school and the season changing, allergists can expect to see an increase in patients.

News
June 10, 2024
4 min read
Save

Commonality of child food allergies highlight importance of prevention and treatment

Allergic disease affects 40% of school-aged children in Australia and 45% of food allergies among infants persist until age 10 years, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

News
February 26, 2024
2 min read
Save

Prior COVID-19 infection does not impact allergic asthma severity in children

WASHINGTON — Among children with allergic asthma, disease severity between those with vs. without a COVID-19 infection in 2020 was similar when assessed after 3 years, according to study results.

News
January 18, 2024
3 min read
Save

Early sublingual immunotherapy for allergic rhinitis reduces risks for allergic asthma

Children who begin sublingual immunotherapy for allergic rhinitis at age 5 years have less risk for developing allergic asthma than children who begin this treatment later, according to a study published in Allergy.

News
August 03, 2023
6 min read
Save

Five trends will influence care for allergic asthma

PARK CITY, Utah — Five trends will shape treatment for allergic airway diseases in the years ahead, according to a keynote speaker.

News
July 20, 2023
3 min read
Save

Sublingual immunotherapy improves bronchial epithelial antiviral resistance

Sublingual immunotherapy for house dust mite allergic asthma improved bronchial epithelial antiviral resistance to viral infection, according to a study published in the American Journal of Respiratory and Critical Care Medicine.

News
November 14, 2022
2 min read
Save

Tezepelumab only biologic to consistently reduce exacerbations in severe allergic asthma

LOUISVILLE, Ky. — Of approved biologics for severe, allergic asthma, tezepelumab was the only one to consistently reduce the annualized exacerbation rate across patient subgroups, according to a literature review.

News
September 13, 2022
2 min read
Save

Biomarkers predict effectiveness of dupilumab treatment for moderate to severe asthma

Elevated baseline levels of type 2 biomarkers predicted improved lung function and reduced exacerbation rates with dupilumab among patients with asthma, according to a study in The Journal of Allergy and Clinical Immunology: In Practice.

News
August 26, 2022
4 min read
Save

Patients using immunotherapy for allergy report satisfaction with providers

The use of immunotherapy among patients with multiple allergies and comorbidities not only is prevalent, but it also is linked to higher satisfaction with health care professionals, according to a survey conducted by Health Union.

View more